← All reportsEN한국어

CEG — Research Report (2026-07-23)

TL;DR


1. Business overview

So what: CEG doesn't make anything you'll ever hold — it makes electrons, and it owns the country's biggest fleet of the one power source that runs nonstop without emitting carbon: nuclear reactors.

Constellation Energy Corporation was spun off from Exelon in February 2022 as the standalone generation ("competitive") business, while Exelon kept the regulated wires-and-poles utilities. CEG owns and operates roughly 21 nuclear reactors (~21 GW) plus natural gas, hydro, wind, and solar assets, concentrated in PJM (the mid-Atlantic/Midwest grid) and ERCOT (Texas).

Revenue model: CEG generates electricity and sells it three ways: (1) wholesale into competitive power markets, (2) retail supply contracts to businesses and municipalities, (3) increasingly, long-term bilateral power purchase agreements (PPA) — a contract where a buyer locks in a fixed price for power over many years — directly with data-center operators. It is not a regulated utility with a guaranteed rate of return; its earnings ride real-time and contracted power prices.

Customer concentration: Historically diversified (grid operators, municipal utilities, commercial/industrial). The strategic shift of 2024–2026 is toward a small number of hyperscale tech customers — Microsoft (Three Mile Island/"Crane" restart, $16B 20-year PPA, 835 MW) (Yahoo Finance), Meta (20-year nuclear PPA) (Every Nuclear-Powered Data Center Deal, smrintel.com), and reportedly Amazon (1,920 MW PPA) (enkiai.com). This concentrates counterparty quality (investment-grade tech giants) but also concentrates revenue mix risk into a handful of contracts.

Major structural event: CEG acquired Calpine (gas/geothermal generator) in 2025–2026; to win regulatory approval, it agreed to divest 4.4 GW of PJM gas assets to LS Power for $5B (Constellation press release). Net effect: CEG is shedding secondary gas assets and concentrating into a "nuclear + geothermal premium" portfolio — a deliberate pure-play tilt, not a retreat.


2. Financials (5-year, $ millions unless noted)

So what: Revenue is steady, not explosive (physics — you can't spin up a new reactor in a year); the real story is cash flow finally turning positive in 2025 after years of funding growth from the balance sheet.

FY Revenue Op. Income Op. Margin Net Income OCF Capex FCF Net Debt*
2020 17,603 256 1.5% 589 584 1,747 −1,163 n/a
2021 19,649 −346 −1.8% −205 −1,338 1,329 −2,667 n/a
2022 24,440 495 2.0% −160 −2,353 1,689 −4,042 n/a
2023 24,918 1,610 6.5% 1,623 −5,301 2,422 −7,723 7,128
2024 23,568 4,352 18.5% 3,749 −2,464 2,565 −5,029 4,362
2025 25,533 3,086 12.1% 2,319 4,237 2,949 +1,288 3,609

*Net debt = long-term debt minus cash. Source: EDGAR companyfacts (SEC), CEG CIK 0001868275.

Revenue CAGR 2020→2025: ~7.7%/yr — respectable, not a growth-stock number. Nuclear output is largely fixed by reactor capacity; growth comes from price, not volume, until new capacity (uprates, restarts) comes online.

Why 2024 net income ($3.7B) beat 2025 ($2.3B) despite AI-deal headlines: operating income fell from $4.35B to $3.09B — 2024 included favorable mark-to-market and hedge accounting gains that partly reversed in 2025 (typical for a merchant generator; power-price hedges swing both ways). This is not a deterioration in the underlying nuclear fleet's operations — it's the normal noise of a commodity-exposed income statement.

FCF turned positive in 2025 for the first time since the spin-off. From 2021–2024 CEG burned cash (peak burn −$7.7B in 2023) funding growth capex and working capital around the PPA buildout. 2025's +$1.3B is the first year cash generation outpaced investment — worth watching whether it holds as Calpine integration capex ramps.

Balance sheet: Total assets grew from $48.1B (2021) to $57.2B (2025); stockholders' equity grew from $11.2B to $14.5B. Net debt fell from $7.1B (2023) to $3.6B (2025) even while capex rose — cash generation, not deleveraging via asset sales, drove this (the LS Power divestiture closes later in 2026 and isn't yet reflected).

Shares outstanding fell from 327M (2022) to 312M (2025) — modest net buybacks, not dilution.


3. Unit economics

So what: the one number that matters for a nuclear generator is realized price per megawatt-hour (MWh) versus fleet-wide production cost — nuclear's fuel cost is tiny, so almost every dollar of power price above the "all-in cost to run the plant" (roughly $30–40/MWh across the industry) drops to margin.

CEG does not break out a clean "$/MWh" unit economic line in the GAAP tables provided, but the structural logic is:

(Estimated — CEG's public disclosures don't provide a single clean "$/MWh" cheat-sheet number; the $115/MWh figure above is derived from press-reported deal terms, not company guidance.)


4. Metrics table with the WHY

So what: every ratio below is a lens on the same question — is CEG's scarce nuclear fleet worth the price the market is charging for it?

Metric CEG value Why this matters here
P/E (price-to-earnings — price per $1 of annual profit) ~36.6× trailing (at $271.62, 2025 EPS ~$7.43) High for a power generator; the market is pricing in AI-deal growth, not today's earnings
EV/EBITDA (enterprise value ÷ cash-flow-proxy earnings, debt-neutral) ~3 turns above peer Vistra per Goldman Sachs (Yahoo Finance) The scarcity premium for owning nuclear, quantified
Revenue CAGR (2020–2025) ~7.7%/yr Nuclear output is capacity-capped; growth is priced, not volumed
OPM trend (operating margin) 18.5% (2024) → 12.1% (2025) Slope, not level, tells you if pricing power is holding — here it dipped on hedge/mark-to-market noise
FCF (free cash flow — cash left after running the business and paying for growth) −$5.0B (2024) → +$1.3B (2025) The cash-flow inflection point that funds dividends/buybacks without more debt
Net debt $7.1B (2023) → $3.6B (2025) Falling despite rising capex — capital discipline is real, not just a story
Shares outstanding 327M (2022) → 312M (2025) Mild buybacks, no stealth dilution
PPA backlog vs. market cap 5,650+ MW of long-term contracts announced against a ~$85B market cap How much of the AI story is already contracted vs. still speculative

4b. Sector valuation benchmarks

So what: CEG is expensive even for an expensive sector — the premium is the whole investment debate.


5. Ownership & management

So what: management is executing the AI-power pivot fast — the open question is discipline on price paid, not strategic direction.


6. M&A track record

So what: CEG's two biggest deals (Calpine acquisition, LS Power divestiture) both point the same direction — trading breadth for a cleaner, higher-quality nuclear/geothermal story.


7. Market & value-chain position

So what: CEG doesn't compete on price like a normal power company — it holds a bottleneck asset (existing licensed nuclear reactors) that can't be replicated on a relevant timescale.


8. PE/quality lens

So what: a private-equity buyer would love the scarcity and contracted cash flows; would fear paying today's public-market premium and inheriting regulatory risk they can't control.


9. Bull / Base / Bear (attributed)

So what: Wall Street is split between "own the irreplaceable asset" and "you're paying too much for it" — both camps agree on the business, disagree on the price.

Bull — Morgan Stanley (Overweight, PT raised to $364 from $359): confidence in CEG's premium nuclear franchise and PPA pipeline despite the 2026 sector pullback. BofA also upgraded to Buy, projecting double-digit growth through 2026 (Investing.com).

Base — Consensus (21 analysts, mean target $367–368, street high $441): 19 of 21 rate Buy/Outperform, but targets have been trimmed across the board since February 2026 as banks factor in updated contracting timelines and more conservative long-term multiples (TIKR, Simply Wall St).

Bear — Goldman Sachs (Neutral, $305 PT): the valuation itself is the risk — CEG trades ~3 turns above Vistra on forward EV/EBITDA with the lowest FCF yield in Goldman's coverage, meaning the price already assumes scarcity premium, PPA optionality, and Calpine synergies all land cleanly (Yahoo Finance). Citigroup (Neutral, PT cut to $297 from $348) flagged PJM reliability-market risk in its July 2026 downgrade (TheStreet). Barclays' 2029 earnings outlook sits below consensus, citing execution risk.

Catalysts: FERC's final order on Crane; more hyperscaler PPA announcements; PJM rule clarity; Q2 2026 earnings (~Aug 6, 2026).

What would prove the thesis wrong: a FERC delay/denial on Crane; a PJM ruling capping merchant power prices; a hyperscaler PPA renegotiation/cancellation; sustained margin compression below 2025's 12%.


10. Practitioner decision layer

10a. Reverse expectations (Mauboussin-style approximation — not a DCF)

At ~$271.62/share and 2025 GAAP EPS of ~$7.43, CEG trades at ~36.6× trailing P/E. Consensus 2026 EPS is ~$11.74, implying a forward P/E of ~23× — a premium to typical regulated-utility multiples (14–18×).

For that multiple to be "earned," the market needs sustained double-digit EPS growth for several years. Judgment: stretched, not implausible — plausible given signed contracts, but leaves no margin for a single miss. This is a rough consensus-and-multiple sanity check, not a DCF.

10b. Variant perception

  1. Consensus believes: CEG's nuclear-to-AI pivot justifies a structural re-rating above historical multiples; 19 of 21 analysts rate it Buy.
  2. This report's differentiated view: None found beyond what Goldman Sachs and Citigroup have already published.
  3. Evidence: Multiple banks have already cut targets since February 2026 citing exactly the valuation/execution risks a variant view would raise.
  4. Consensus agreement — no supported variant perception found. The bear case here is already Wall Street's own stated Neutral view, not a contrarian call.

10c. Probability-weighted expected value

Scenario Probability Target price Key condition Source/assumption
Bull 30% $400 Crane on schedule, favorable PJM rules, new PPAs Morgan Stanley/BofA trajectory
Base 45% $320 Roughly on plan, modest multiple compression Consensus mean blended down for target-cut trend
Bear 25% $250 FERC delay, PJM caps, margin compression persists Goldman/Citi valuation concerns

EV = 0.30×400 + 0.45×320 + 0.25×250 ≈ $326.50 — modestly above the current price, but the wide scenario spread argues against treating this as a clean margin of safety.

10d. Pre-mortem (assume price halved to ~$136 by mid-2028)

  1. FERC/regulatory delay or denial on Crane, or PJM rules cap merchant prices. Early signal: docket delays; weak PJM capacity auction results.
  2. A hyperscaler PPA is renegotiated, delayed, or cancelled. Early signal: an 8-K disclosing a PPA amendment; a customer's capex guidance cut.
  3. Calpine integration costs or divestiture proceeds disappoint, FCF reverts negative. Early signal: FCF flipping negative again; net debt rising.

10e. KPI driver tree and sensitivity

Core drivers: realized price/MWh × nuclear capacity factor (~90%+, limited upside) × operating margin (12–18% band).

10f. Scuttlebutt proxies


Decision (Educational — not investment advice)


📚 What this company teaches

  1. Scarcity beats growth rate. CEG's revenue grows slowly (~7.7%/yr, capacity-capped) yet commands a premium multiple because what it has cannot be built quickly by anyone else.
  2. Cash flow and net income can tell different stories in the same year. 2025 net income fell from 2024, but FCF turned positive for the first time — GAAP profit includes hedge-accounting noise cash flow doesn't.
  3. A "premium" valuation is a bet on things staying perfect. When multiple banks independently flag the same valuation gap, the market has already priced in the good news.

Self-test question: If CEG's forward P/E is ~23× versus a typical regulated utility's 14–18×, what would need to be true about future earnings growth for that premium to be "worth it" — and what single calendar event could most quickly prove that right or wrong?


📖 Glossary


Sources cited inline. EDGAR/GAAP figures per SEC companyfacts (CIK 0001868275). Market price, analyst targets, and deal details are as reported in web sources as of 2026-07-23 — re-verify against a live quote before any decision.


Note: I couldn't save this to investing/ceg-2026-07.md — the Write tool needs your approval first. Want me to retry the write, or is the inline output sufficient for now?